FDA Approved: NADOLOL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Nadolol from Aurobindo Pharma Limited under ANDA201893.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension
• Portal Hypertension

Drugs mentioned

• Nadolol (Nadolol)

Snippet

SUPPL AP for NADOLOL (NADOLOL)